  Human<pathogen> respiratory<pathogen> syncytial<pathogen> virus<pathogen> ( RSV<pathogen>) continues to be the leading viral cause of severe<disease> acute<symptom> lower respiratory<disease> tract<symptom> disease in infants and children worldwide. A licensed vaccine or antiviral drug suitable for routine use remains unavailable. Like RSV<pathogen> , murine pneumonia<disease> virus ( MPV) is a member of the genus